Tissue necrosis factor (TNF)-α, interleukin (IL)-1, and IL-6 have been reported to be upregulated in the setting of diabetes-related CKD and are known to stimulate an inflammatory cascade that contributes to the progression of CKD (91–94). The gene discussed is IL6; the disease is chronic kidney disease.